Delivery Order SPE2DB20D1110-SPE2DB25FK41J
- Not listed
- The Defense Logistics Agency awarded a $1,218.07 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Xtampza ER 27 mg capsules (100-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xtampza ER 27 mg capsules (100-count units) on September 12, 2025, with a ceiling value of $1,092.43. This firm fixed price delivery order has an ultimate completion date of September 15, 2025, and represents a non-competitive award under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's...
- The Defense Logistics Agency awarded a $1,344.17 delivery order to AmerisourceBergen Drug Corp on June 13, 2025, for the supply of Xtampza ER 36 mg capsules (100-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 16, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,538.92 to AmerisourceBergen Drug Corp for XTAMPZA ER 36 mg capsules (100 count), with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete openly for federal medical procurement requirements....
- The Defense Logistics Agency awarded a delivery order valued at $1,703.99 to AmerisourceBergen Drug Corp for 100 capsules of Xtampza ER 36 mg, a long-acting opioid pain medication. The contract was competitively awarded with no set-aside designation, utilizing firm fixed pricing under a delivery order contract type. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,085.35 for XTAMPZA ER 18 mg capsules (100-count units) on July 11, 2025, with an ultimate completion date of July 14, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for XTAMPZA ER 18 mg capsules (100-count packages) valued at $6,281.84 under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Department of Defense Medical Supply Chain awarded a delivery order valued at $9,654.96 to AmerisourceBergen Drug Corp for XTAMPZA ER CAPS 36MG, a pharmaceutical product. This firm fixed price delivery order, issued on July 14, 2025, represents a child contract under a larger indefinite delivery vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. The award was competitively awarded...
- This is a $3,534.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xtampza ER 36 mg capsules, a prescription pain medication, with a period of performance through June 2025. The award is not set aside and was made through open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,299.87 to AmerisourceBergen Drug Corp for XTAMPZA ER CAPS 13.5MG, a pharmaceutical product. The contract was competitively awarded without a set-aside designation on April 23, 2025, with an ultimate completion date of April 24, 2025. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award employs firm fixed price terms, typical of delivery orders...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK41JDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xtampza ER 36 mg capsules (100-count units) with a ceiling value of $8,590.87. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitively awarded contract with no set-aside designation. The award is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's broader relationship with the federal government as a critical pharmaceutical distributor. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As the prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems. The company's consistent receipt of competitively awarded delivery orders across diverse therapeutic domains demonstrates its capability to meet federal medical procurement requirements and serve critical customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/15/25 |